May 24, 2017 - By Dolores Ford
Among 15 analysts covering ASML Holding NV (NASDAQ:ASML), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. ASML Holding NV had 22 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of ASML Holding NV (ADR) (NASDAQ:ASML) has “Buy” rating given on Thursday, January 21 by Bryan Garnier & Cie. The stock of ASML Holding NV (ADR) (NASDAQ:ASML) has “Underperform” rating given on Thursday, October 15 by RBC Capital Markets. The firm has “Hold” rating by Deutsche Bank given on Friday, January 22. The stock of ASML Holding NV (ADR) (NASDAQ:ASML) earned “Neutral” rating by Credit Suisse on Tuesday, January 17. The stock of ASML Holding NV (ADR) (NASDAQ:ASML) has “Neutral” rating given on Wednesday, February 8 by BNP Paribas. The firm earned “Neutral” rating on Wednesday, August 17 by Bank of America. The firm has “Add” rating given on Tuesday, July 21 by SNS Securities. Susquehanna downgraded the stock to “Neutral” rating in Tuesday, April 19 report. The firm has “Buy” rating by Berenberg given on Friday, August 28. UBS upgraded the stock to “Buy” rating in Friday, March 10 report. See ASML Holding NV (ADR) (NASDAQ:ASML) latest ratings:
10/03/2017 Broker: UBS Old Rating: Neutral New Rating: Buy Upgrade
08/02/2017 Broker: BNP Paribas Old Rating: Underperform New Rating: Neutral Upgrade
30/01/2017 Broker: ABN Amro Rating: Buy Initiate
19/01/2017 Broker: Citigroup Old Rating: Buy New Rating: Neutral Downgrade
17/01/2017 Broker: Credit Suisse Rating: Neutral Reinitiate
19/12/2016 Broker: Bank of America Old Rating: Neutral New Rating: Buy Upgrade
Among 7 analysts covering Amgen Inc. (NDAQ:AMGN), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Amgen Inc. has $209 highest and $165 lowest target. $185.29’s average target is 20.26% above currents $154.07 stock price. Amgen Inc. had 8 analyst reports since April 5, 2017 according to SRatingsIntel. Robert W. Baird maintained the stock with “Neutral” rating in Monday, May 1 report. On Tuesday, May 23 the stock rating was maintained by Jefferies with “Hold”. The firm has “Buy” rating given on Tuesday, May 23 by BMO Capital Markets. As per Friday, April 28, the company rating was maintained by Cowen & Co. Oppenheimer maintained Amgen, Inc. (NASDAQ:AMGN) rating on Friday, April 7. Oppenheimer has “Outperform” rating and $189 target. Credit Suisse maintained the shares of AMGN in report on Wednesday, April 5 with “Hold” rating. As per Wednesday, April 26, the company rating was maintained by Bernstein. The firm has “Hold” rating by Jefferies given on Wednesday, April 5.
ASML Holding N.V. is a holding company. The company has market cap of $58.22 billion. The Firm is a maker of chip-making equipment. It has a 29.61 P/E ratio. The Firm is engaged in the development, production, marketing, selling and servicing of semiconductor equipment systems, consisting of lithography systems.
The stock decreased 0.22% or $0.3 during the last trading session, reaching $133.91. About 100 shares traded. ASML Holding NV (ADR) (NASDAQ:ASML) has risen 44.52% since May 24, 2016 and is uptrending. It has outperformed by 27.82% the S&P500.
Amgen Inc. is a biotechnology company. The company has market cap of $110.78 billion. The Firm discovers, develops, makes and delivers various human therapeutics. It has a 14.6 P/E ratio. It operates in human therapeutics segment.
Investors sentiment decreased to 1.09 in Q4 2016. Its down 0.17, from 1.26 in 2016Q3. It worsened, as 98 investors sold Amgen, Inc. shares while 488 reduced holdings. 111 funds opened positions while 527 raised stakes. 561.98 million shares or 1.23% less from 568.98 million shares in 2016Q3 were reported. Heritage Wealth Advsrs has 0.4% invested in Amgen, Inc. (NASDAQ:AMGN) for 4,152 shares. Arete Wealth Advisors Ltd Limited Liability Company reported 7,506 shares stake. Inv Centers Of America Inc accumulated 9,216 shares. 5,394 were accumulated by Capstone Investment Advisors Ltd. Moreover, Fuller Thaler Asset Mgmt Inc has 0.02% invested in Amgen, Inc. (NASDAQ:AMGN) for 8,980 shares. Commonwealth Equity Services Inc reported 189,152 shares. Endurant Cap Management Ltd Partnership accumulated 4,358 shares. Quantum Capital Management invested 0.28% of its portfolio in Amgen, Inc. (NASDAQ:AMGN). Thomas J Herzfeld Advsr Incorporated reported 700 shares stake. M Kraus And reported 0.24% stake. Sunbelt Secs has invested 0% in Amgen, Inc. (NASDAQ:AMGN). First Natl Trust accumulated 32,068 shares. Jupiter Asset holds 0.38% or 70,461 shares. Jacobs Levy Equity Mgmt invested in 279,971 shares. Ajo Limited Partnership stated it has 1.40M shares or 0.84% of all its holdings.
Analysts await Amgen, Inc. (NASDAQ:AMGN) to report earnings on July, 26. They expect $3.09 earnings per share, up 8.80% or $0.25 from last year’s $2.84 per share. AMGN’s profit will be $2.22B for 12.47 P/E if the $3.09 EPS becomes a reality. After $3.15 actual earnings per share reported by Amgen, Inc. for the previous quarter, Wall Street now forecasts -1.90% negative EPS growth.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.